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Abstract
Resistance to β-lactam antibiotics in enteric Gram-negative bacilli may be difficult to detect using
standard methods of either Kirby-Bauer disc diffusion (KBDD) or broth dilution for minimal
inhibitory concentration (MIC). This difficulty is due to genetic differences in resistance
determinants, differences in levels of gene expression, and variation in spectra of enzymatic activity
against the substrate β-lactams used for susceptibility testing. We have examined 95 clinical isolates
reportedly susceptible to ceftazidime and ceftriaxone, as originally determined by either KBDD or
MIC methods. The organisms studied here were isolated in 2002 from two pediatric hospital
centers (Seattle, USA and Shanghai, China). They belong to the inducible β-lactamase producing
Gram-negative bacilli, such as Enterobacter spp., Citrobacter spp., Serratia spp., Morganella spp.,
Providencia spp., and Proteus vulgaris. A Kirby-Bauer disc approximation (KBDA) method identified
inducible phenotypes of third-generation cephalosporin resistance in 76% of isolates, which would
otherwise be considered susceptible by standard KBDD methods.
Introduction
Nosocomial infections due to antibiotic-resistant, enteric
Gram-negative bacilli have increased at an alarming rate
in intensive care facilities, and are frequently associated
with immunocompromised hosts, for whom they may be
particularly devastating [1-5]. Multidrug-resistant
Escherichia coli and Klebsiella spp. (as well as other Entero-
bacteriaceae) carrying plasmid-borne extended-spectrum
β-lactamases (ESBLs) have attracted much interest among
clinical microbiologists, infectious disease specialists, and
infection control practitioners [6-8]. In contrast, the car-
riage of chromosomally encoded AmpC β-lactamases by
these organisms has been deemed a commensal trait of
uncertain consequence, and thus the management of such
infections has not benefited from the multidisciplinary
approach taken with ESBL infections [9-12].
Standard Kirby-Bauer disc diffusion (KBDD) methods
and automated minimal inhibitory concentration (MIC)
instruments used in most clinical laboratories do not
readily detect ampC-type of inducible resistance. Therapy
based on such susceptible reports may result in selection
of resistance in vivo [9-13]. A few instructive studies have
reported that the observation of increased MICs to third-
generation cephalosporins using high-density inocula
(increasing sensitivity for detection of derepressed mutant
Published: 15 July 2004
Annals of Clinical Microbiology and Antimicrobials 2004, 3:13 doi:10.1186/1476-0711-3-13
Received: 23 March 2004
Accepted: 15 July 2004
This article is available from: http://www.ann-clinmicrob.com/content/3/1/13
© 2004 Qin et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media 
for any purpose, provided this notice is preserved along with the article's original URL. Annals of Clinical Microbiology and Antimicrobials 2004, 3:13 http://www.ann-clinmicrob.com/content/3/1/13
Page 2 of 6
(page number not for citation purposes)
subpopulations) may be used to predict clinical failures
[14,15]. To address this gap, the National Committee for
Clinical Laboratory Standards (NCCLS) has included
warnings such as 'Enterobacter,  Citrobacter, and Serratia
spp. may develop resistance during prolonged therapy
with third generation cephalosporins' in its interpretive
guideline publications [16]. However, methods that can
be used to detect such resistance have not been suggested.
In this study, we used the Kirby-Bauer disc approximation
(KBDA) method [17-19] to detect and characterize several
phenotypes of inducible β-lactamase production. The
interpretation of antibiotic susceptibilities was based on a
combination of inhibitary zone sizes and zone morphol-
ogies near a potent agent of β-lactamase induction.
Materials and methods
Bacterial isolates and testing conditions
The 95 clinical isolates of Enterobacter, Citrobacter, Serratia,
Morganella, Providencia, and Proteus vulgaris examined in
this study were considered etiologic agents in cases of
meningitis, bacteremia, pneumonia, wound, and urinary
tract infections. Of the 95 strains tested, 56 were recovered
during the fourth quarter of 2002 at Children's Hospital
and Regional Medical Center (CHRMC) in Seattle, WA,
and 39 were recovered during 2002 at Shanghai Chil-
dren's Medical Center (SCMC), a sister hospital in Shang-
hai, China. When initially tested by standard KBDD and/
or Vitek MIC methods, these isolates were interpreted as
susceptible to third-generation cephalosporins (i.e.,
ceftazidime and ceftriaxone), based on NCCLS criteria
[16]. In addition, control strains of Escherichia coli ATCC
25922 and a cephalosporin-resistant E. cloacae strain A (as
shown in fig. 1f) were included in the study.
Testing conditions featured standard KB discs (Becton
Dickinson Microbiology Systems, BBL, Sparks, MD, for
CHRMC; Oxoid Limited, Basingstoke, Hampshire, Eng-
land, for SCMC) and Mueller Hinton agar plates (BBL)
with 35°C overnight incubation (~16 hours) in ambient
air for KBDA analysis (NCCLS M2-A7) [20]. Standard 0.5
McFarland saline suspensions of bacteria were used to
inoculate the Mueller Hinton agar media confluently with
a cotton swab. The resultant zones of inhibition were
measured with a caliper using transmitted light. We deter-
mined the diameter of circular zones of inhibition and the
shortest radius of inducer-blunted zones.
KBDA for detection of third-generation cephalosporin 
resistance
The disc approximation technique was used as previously
described [17] to detect inducible resistance to third-gen-
eration cephalosporins. We used cefoxitin (FOX) as a β-
lactamase induction agent, and cefotaxime (CTX) and
ceftazidime (CAZ) as the third-generation cephalosporin
reporter agents [18,19,21]. Cefepime (FEP) was used for
fourth-generation cephalosporin susceptibility testing.
Based on preliminary results (described below), we
selected a 15-mm edge-to-edge distance between the discs
for  β-lactamase induction testing of all isolates in the
study. We also reviewed the initial susceptibility results of
the 95 isolates to gentamicin (GM) and ciprofloxacin
(CIP). To determine CAZ and CTX inhibitory activities
upon induction, we doubled the radius measurements of
zones of inhibition in the direction of the FOX discs, for
direct comparison with the diameters of unaffected zones.
Median zone measurement values were analyzed using
the Wilcoxon signed-ranks test.
Results
Determination of disc distance for KBDA and 
measurements of antibiotic zones of inhibition
A pilot KBDA test was carried out with 13 strains of enteric
Gram-negative bacilli, including E. coli ATCC 25922, C.
freundii (n = 3), E. aerogenes (n = 1), E. agglomerans (also
known as Pantoae agglomerans, n = 2), E. cloacae (n = 3), P.
rettgeri (n = 1), and S. marcescens (n = 2). For each strain,
we placed a FOX disc in the center and approximated CTX
and CAZ discs on each side, comparing zones of inhibi-
tion for edge-to-edge distances of 15, 20, and 25 mm. FOX
showed no effect on CTX nor CAZ susceptibilities in E. coli
ATCC 25922, the E. agglomerans, and the P. rettgeri at any
given disc distance. The most easily discernable patterns
of FOX induced zone distortions were observed using the
15-mm disc distance in the remaining organisms.
We then tested each of 95 isolates against paired antibiot-
ics using the 15-mm testing method. The test was repeated
at least once with each organism. Averages of the zone
measurements were used for final analysis. In the absence
of FOX influence, the median zone sizes (and ranges) for
CAZ and CTX were 27 mm (20–34 mm) and 29 mm (23–
34 mm), respectively. With FOX induction, the radius
from the center of the disc to the distorted zone edge near
FOX ranged from 8 to 15 mm for CAZ and 8 to 16 mm for
CTX, corresponding to median zone diameters of 23 mm
and 24 mm for CAZ and CTX, respectively. For both CAZ
and CTX, the FOX-induced zones were significantly
smaller (p <0.0001) than the uninduced zones.
Interpretation of drug susceptibility patterns
Based on patterns of zone distortion, five types of suscep-
tibility could be readily recognized among the test results.
The five patterns (or zone morphologies) reflect incre-
mental, visually discernable levels of bacterial resistance
to CTX and CAZ, due to varying degrees of ampC induc-
tion (fig. 1a,1b,1c,1d,1e,1f). The two "extreme" patterns
of drug susceptibility (fig. 1a and 1f) may be easily
interpreted as drug-sensitive and drug-resistant, respec-
tively. Resistant ('R') strains had no zones of inhibitionAnnals of Clinical Microbiology and Antimicrobials 2004, 3:13 http://www.ann-clinmicrob.com/content/3/1/13
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around any of the three discs (fig. 1f, a CTX-resistant con-
trol  E. cloacae strain A), while susceptible ('S') strains
exhibited zones of inhibition above break points for CTX
(≥ 23 mm) and CAZ (≥ 18 mm) and no growth between
CTX-FOX or CAZ-FOX pairs (shown by E. cloacae 02212 in
fig. 1a). Fifteen organisms were classified as susceptible to
CTX and CAZ by the KBDA method: C. freundii (n = 1), C.
koseri (n = 4), E. agglomerans (n = 2), E. amnigenus (n = 2),
E. asburiae (n = 1), E. cloacae (n = 3), P. rettgeri (n = 1), and
S. liquefaciens (n = 1).
However, not all patterns of inhibition could be judged
solely by zone size measurement and thus interpreted
using standard NCCLS guidelines. Hence, we distin-
guished three additional patterns, based on type of zone
morphology around CTX (or CAZ) next to FOX and on
bacterial growth between the disc pairs. 1) Slight growth
('Sl'-type zones) near FOX, but no identifiable zone dis-
tortion around CTX or CAZ (fig. 1b), was observed for 8
isolates: E. agglomerans (n = 5), E. sakazakii (n = 2), and P.
vulgaris (n = 1). All exhibited zones of inhibition above
the breakpoints for CTX and CAZ, and were thus inter-
preted as susceptible to these agents. 2) Zones of inhibi-
tion shaped like the letter 'C' ('C'-type zones), with
bacterial growth pressing towards CTX or CAZ as a result
of FOX induction (fig. 1c,1d), were observed (n = 23).
Although the inducible growth was partially cleared by
inhibitory action of FOX, producing letter 'C'-shaped
zones, distortions of circular zones of inhibition around
CTX were apparent. 3) Zones of inhibition resembling the
letter 'D' ('D'-type zones), due to a flat edge of growth on
both sides of FOX pressing against CTX and CAZ (fig. 1e),
were also observed (n = 49). Because C- and D-types of
growth around CTX and CAZ were clearly influenced by
the close proximity of FOX, known for its potent effect on
ampC induction, we have classified strains exhibiting such
resistance patterns as 'Resistant (Inducible)'. Table 1 sum-
marizes KBDA testing results for all 95 isolates, grouped
into S-, Sl-, C- and D-types of zone categories. By classify-
ing as 'susceptible' only those strains exhibiting S- and Sl-
type growth patterns by the KBDA method, we have iden-
tified inducible resistance phenotypes in 76% (72/95) of
the study isolates that were all reportedly susceptible to
third-generation cephalosporins by standard KBDD or
MIC methods. Inducible CTX resistance occurred in 80%
(45/56) of CHRMC isolates and 69% (27/39) of SCMC
isolates. The resistance patterns are not directly compara-
ble due to differences in species distribution between the
two groups. In figure 2, we summarize CTX susceptibility
data generated by the KBDA method, by species. The same
KBDA method was also employed to examine FEP suscep-
tibility under the induction of FOX in all 95 isolates. FOX
induction had minimal effect on the size or shapes of FEP
zones of inhibition against this group of isolates (data not
shown).
Types of zones of inhibition determined by KBDA method Figure 1
Types of zones of inhibition determined by KBDA method. 
With FOX discs in the center, CTX discs are placed 15 mm 
to the left of FOX, while CAZ discs are 15 mm to the right 
of FOX as shown in fig 1a. (a) Susceptible zone: no growth 
between FOX and CTX/CAZ, E. cloacae 02212. (b) Sl zone: 
slight growth between FOX and CTX/CAZ, E. agglomerans 
02039. (c) C zone: CTX zone distortion near FOX, S. marc-
escens 02319. (d) C zone: CTX zone distortion near FOX. M. 
morganii 02325. (e) D zone: CTX and CAZ zone truncation 
near FOX, E. aerogenes 02324. (f) Resistant zone: no zone of 
inhibition around any disc, E. cloacae strain A.
a. E. cloacae 02212
CTX FOX CAZ
b. E. agglomerans 02039
c. S. marcescens 02319
d. M. morganii 02325
e. E. aerogenes 02324
f. E. cloacae strain AAnnals of Clinical Microbiology and Antimicrobials 2004, 3:13 http://www.ann-clinmicrob.com/content/3/1/13
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Discussion
Although in vitro susceptibility testing remains the corner-
stone of clinical antibacterial therapy, not all naturally
occurring mechanisms of resistance can be detected by
standard laboratory methodologies [14]. Over 15 years
ago, Sanders et al. [10,11] reported the emergence of bac-
terial resistance during cephalosporin treatment occurred
in some 20–40% of systemic infections with these Gram-
negative bacilli, accounting for treatment failure or
relapse in at least 10% of such cases. Yet in the intervening
years, individual hospital antibiograms have reported 75–
90% of E. cloacae and S. marcescens isolates to be suscepti-
ble to third-generation cephalosporins. Thus, without
accurate laboratory detection and informative reporting
of such occult resistance phenotypes, the treatment of
Gram-negative infections may remain suboptimal.
Of 95 isolates reported 'susceptible' to CTX and CAZ by
conventional KBDD testing, 72 isolates (76%) exhibited
C- and D-type inducible AmpC resistance. Moreover, the
rates of resistance among this representative sample of
common pathogens were rather alarming. Of the E.
Distribution of inducible resistance detected by KBDA among bacterial genera and species Figure 2
Distribution of inducible resistance detected by KBDA among bacterial genera and species.
Table 1: Types of zones of inhibition around CTX determined by KBDA.
KBDA zone types around CTX No. organisms (n = 95) Percentage of the zone type Susceptibility interpretation
S-type 15 16% Susceptible 24%
Sl-type 8 8%
C-type 23 24% Resistant (Inducible) 76%
D-type 49 52%
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cloacae  isolates, representing nearly 30% of the study
strains, we found inducible resistance as high as 90% (fig.
2). Likewise, E. aerogenes, S. marcescens, and C. freundii,
together accounting for 27% of study strains, exhibited a
combined inducible resistance rate of 94%. This type of
occult resistance phenotype may be missed by the stand-
ard testing methods and may have contributed to the fre-
quency of treatment failures previously observed [9-13].
Distorted patterns of antibiotic zones of inhibition in the
presence of β-lactamase induction agent FOX may provide
clinical microbiologists with information not evident
from conventional interpretations of zone size for this
group of Gram-negative bacilli [18]. The statistical signif-
icance of the zone sizes between CTX and CTX-next-to-
FOX strongly supports the notion of incorporating zone
morphology into interpretation of antibiotic susceptibil-
ity results. We consider both 'C' and 'D' zone morpholo-
gies to be indicative of inducible resistance, and thus
intend to categorize isolates exhibiting 'C' and 'D' zones as
potentially resistant to third-generation cephalosporins.
One potential strategy for communicating such data to cli-
nicians would be to introduce a dual descriptor (such as
'S/R') to encompass results of both conventional and
KBDA methods; a second level interpretation (such as
'Susceptibility testing indicates that resistance to this agent
may emerge during prolonged therapy; this agent may
still be useful for treatment of uncomplicated infections of
the urinary tract, where high drug concentrations can be
achieved') would accompany this descriptor [16,22,23].
The variety of zone phenotypes generated by KBDA may
provide some insight into the regulation of these impor-
tant genetic determinants. The distinctive zone morphol-
ogies observed among study strains may be indicative of
the action of an auxiliary regulatory gene(s), such as ampR
and ampD, on ampC expression rather than, for instance,
point mutations in ampC promoters or regulators [24-27].
In contrast, the unmistakable no-zone type of AmpC
resistance (a control strain shown in fig. 1f) is associated
with permanent ampC derepression typically caused by
promoter point mutations [28] or mutations in regulatory
genes ampD or ampR [29]. Historically designated as de
novo resistance, this phenotype would not be missed by
conventional MIC and KBDD methods.
Consistent with previous findings, third-generation
cephalosporin resistance conferred by ampC  induction
did not predict FEP resistance in this group of Gram-neg-
ative bacilli [30,31]. Many clinical isolates exhibiting
inducible CTX and/or CAZ resistance in this collection
remained susceptible to the fourth-generation cepha-
losporin FEP; those isolates resistant to FEP may have
utilized a distinct mechanism, such as blockage of drug
uptake [32,33], to escape its antibacterial activity. In the
treatment of invasive infections caused by such patho-
gens, continued efficacy of alternative or combination
therapy is supported by GM or CIP susceptibility at
CHRMC [34]. Of interest, all 7 organisms resistant to
these agents (5 strains resistant to GM and 2 resistant to
CIP) were isolated from SCMC. No conclusive statements,
however, can be made regarding the comparative rates of
drug resistance between the two institutions due to differ-
ing bacterial genus and species make-up of the two
collections.
The extent to which generalized treatment recommenda-
tions can be based solely on isolation of so-called SPICE-
MP (Serratia,  Proteus  spp. – Indole positive,Citrobacter,
Enterobacter, Morganella, and Providencia) organisms, the
'usual suspects' for ampC  carriage, remains limited
[22,23]. Those 23 (24%) isolates that did not exhibit rec-
ognizable zone distortion patterns were considered sus-
ceptible to CTX by KBDA, although some or all may
contain a similar array of ampC determinants to the strains
that exhibited resistant patterns. Of the AmpC family of β-
lactamases, the spectrum of activity witnessed in our study
isolates encompasses at least three Bush groups: group 1
for the majority, but group 2b for C. koseri and group 2e
for P. vulgaris [35]. Thus, the genetics of both the struc-
tural ampC sequences and their regulatory pathways may
still be highly polymorphic. In addition, organisms host-
ing both ESBL and ampC determinants have been found
in many enteric Gram-negative bacilli [6,36], compound-
ing the difficulties in recognition and detection. In short,
accurate species identification does not allow simple
assignment of the isolates to either ESBL- or AmpC-like β-
lactam susceptibility patterns.
This study supports the use of a modified KBDD method,
which would provide simple, visual information about
bacterial resistance phenotypes. Further characterization
of KBDA zone morphologies, considered jointly with
zone size measurement, can be used to detect phenomena
that even a refined quantitative system would be unable
to measure. Laboratory tools need to be developed, proto-
cols standardized and guidelines established to provide
accurate detection and reporting practices that will enable
more effective treatment strategies for these difficult
infections.
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